Presentation TCT 2024 TCT 40: Sirolimus- vs. Paclitaxel-Coated Balloons for Treatment of Coronary Artery Disease Presenter: Pier Pasquale Leone October 28, 2024
Presentation TCT 2024 TCT 436: Paclitaxel-Coated Balloon With Urea or Iopromide as the Excepient for Treatment of Coronary Artery Disease: A Propensity-Score Adjusted Comparison Presenter: Mauro Gitto October 28, 2024
Presentation TCT 2024 TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis Presenter: Gakuto Bando October 28, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News TCT 2023 Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis Todd Neale November 02, 2023
Presentation TCT 2023 TCT 476: Biological Differences of Three Paclitaxel- and Sirolimus-coated Balloons on Coronary Lesions in a Rabbit Model Presenter: Kazuki Aihara October 25, 2023
Presentation TCT 2023 TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons Presenter: Matthias Bossard October 25, 2023
Presentation TCT 2023 TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry Presenter: Young-Sun Park October 25, 2023
News Conference News TCT 2023 Comparing DCBs in De Novo CAD: Drugs, Design Matter Caitlin E. Cox October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
Presentation TCT 2023 TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model Presenter: Teruo Sekimoto October 25, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
Presentation TCT 2022 Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial Presenter: Christos Rammos September 17, 2022
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
Presentation TCT 2020 TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease Presenter: Brian Forrestal October 14, 2020
News Conference News TCT 2019 PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries L.A. McKeown October 04, 2019
Presentation TCT 2019 Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration Presenter: Robert Byrne September 28, 2019